Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
  1. 8-K Event Executive or director change
  2. 4 Grant or award Chief Financial Officer acquired 7,500 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 10,000 shares (grant or award)
  4. 4 Grant or award Chief Development Officer acquired 12,500 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 31,250 shares (grant or award)
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Open-market sale President and CEO sold 15,000 shares at $32.14 ($482,171)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4 Option exercise President and CEO acquired 40,000 shares (option exercise)
  18. SC 13G Stake Amended Statement of Ownership
  19. 8-K Event Other events
  20. 4 Open-market sale Chief Scientific Officer sold 14,779 shares at $47.56 ($702,889)

Page 18 of 36 · 707 filings